In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and self-amplifying messenger RNA (sa-mRNA) pioneer Arcturus ...

The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...

Fairfield and UConn researchers found that lifestyle factors like BMI, birth control and stress levels affect perceived COVID-19 vaccine symptoms.

One expert in Indiana expects to see another wave of COVID-19 infections during late spring based on past patterns.

CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the initiation of the sentinel cohort of its Phase 2b clinical trial evaluating Vaxart’s ...

Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies have entered into a joint agreement regarding the co-promotion of ...